Ovid Therapeutics Inc.
OVID- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636651
No open-market purchases or sales by Ovid Therapeutics Inc. insiders were filed in the last 90 days; 130 institutions reported holding it in 13F filings for Q2 2026, worth $395.5M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Ovid Therapeutics Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 64 | 1 | 77 | +14 |
| Shares | 42.3M | 864.8K | 51.7M | +10.2M (+24.5%) |
| Value | $162.6M | $3.32M | $166.3M | +$7.06M (+4.4%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Ovid Therapeutics Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Takeda Pharmaceutical Co Ltd | 7,531,996 | $24.3M | 7.41% |
| Blue Owl Capital Holdings LP | 864,822 | $2.78M | 0.67% |
| FFT Wealth Management LLC | 395,774 | $1.27M | 0.11% |
| Vestal Point Capital, LP | 85,429 | $275.1K | 0.03% |
| Assenagon Asset Management S.A. | 78,479 | $252.7K | 0.00% |
| Tejara Capital Ltd | 73,153 | $235.6K | 0.10% |
| Jane Street Group, LLC | 50,901 | $163.9K | 0.00% |
| Virtu Financial LLC | 24,264 | $78.0K | 0.01% |
| Susquehanna International Group, LLP | 22,220 | $71.5K | 0.00% |
| Newman Dignan & Sheerar, Inc. | 16,522 | $53.2K | 0.02% |
| ProShare Advisors LLC | 14,385 | $46.3K | 0.00% |
| ADAR1 Capital Management, LLC | 13,246 | $42.7K | 0.02% |
| Squarepoint Ops LLC | 11,381 | $36.6K | 0.00% |
| Citadel Advisors LLC | 11,202 | $36.1K | 0.00% |
| China Universal Asset Management Co., Ltd. | 8,178 | $26.3K | 0.01% |
| ICA Group Wealth Management, LLC | 55 | $177 | 0.00% |
| The PNC Financial Services Group, Inc. | 10 | $32 | 0.00% |
Sold out (3)
Institutions that held Ovid Therapeutics Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Jump Financial, LLC | 15,811 | $60.7K |
| Allspring Global Investments Holdings, LLC | 6,294 | $24.2K |
| Russell Investments Group, Ltd. | 57 | $219 |
Not filed for Q4 2023 yet (1)
Institutions that held Ovid Therapeutics Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| CHI Advisors LLC | 864,822 | $3.32M |